Risk factors for acute rejection in 806 cyclosporine-treated renal transplants: A multivariate analysis

Transplantation Proceedings

Volumn 35, Issue 3, 2003, Pages 1061-1063

  Mota, Alfredo ^a   Figueiredo, A ^a   Cunha, M F X ^a   Bastos, M ^a   Pratas, J ^a   Furtado, L ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; PREDNISONE;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; LIVING DONOR; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0038369069     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00306-3     Document Type: Conference Paper

References (10)

1. Cecka M. Surg Clin North Am. 78:1998;133.
2. Almond P.S., Matas A., Gillingham K., et al. Transplantation. 55:1993;752.
3. Koyama H., Cecka J.M. Terasaki P.I., Cecka J.M. Clinical Transplants 1992. 1993;391 UCLA Tissue Typing Laboratory, Los Angeles, Calif.
4. Gjertson D.W. Terasaki P.I., Cecka J.M. Clinical Transplants 2000. 2001;467 UCLA Immunogenetics Center, Los Angeles, Calif.
5. Ferguson RM, Henry M, Elkhammas EA, et al: Presented at the American Society of Transplant Surgeons, 18th Annual Scientific Meeting, Chicago, 1992 (Abstract) p 83.
6. Matas A.J. Transpl Immunol. 6:1998;1.
7. Basadonna G.P., Matas A.J., Gillingham K.J., et al. Transplantation. 55:1993;993.
8. Guidi E., Cozzi M.G., Minetti E., et al. J Am Soc Nephrol. 9:1998;2102.
9. Kerman R.H., Kimball P.M., Lindholm A., et al. Transplantation. 56:1993;1242.
10. Shoskes D.A., Halloran P.F. Transplant Proc. 23:1991;599.